Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Kevin Gaffney
Assistant Research Professor, Pharmacology - (Research Series Track)
Pharmacology
Map Page
Research Area
drug development,
medical research,
rasrx1902,
treatment,
chemotherapy,
colorectal cancer,
small molecule inhibitors,
interleukin-8 pathway,
cxcr2 inhibitors,
molecular biology
Grants
(5)
Sign in to view all grants
Publications
(19)
Recent
Mitigation of cognitive decline and brain pathology after transaortic constriction by Mas agonists
2021
cognitive decline,
brain pathology,
mas agonists,
transaortic constriction,
mitigation
P1‐085: MAS AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE
2019
neurodegenerative disease,
agonists,
treatment,
mas,
research
Improving the Innate Immune Response in Diabetes by Modifying the Renin Angiotensin System
2019
diabetes,
immune response,
renin-angiotensin system,
innate immunity,
medical research
Development of angiotensin II 1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression
2018
chemotherapy-induced myelosuppression,
angiotensin ii 1-7 analog,
oral therapeutic,
development,
treatment
Methods, compounds, and compositions for the treatment of musculoskeletal diseases
2018
musculoskeletal diseases,
treatment methods,
compounds,
compositions,
medical research
A 1-7) reduces pathologies associated with SLE in MRL-lpr mice
2018
systemic lupus erythematosus,
immunology,
animal models,
pathology,
therapeutics
Methods, compounds, and compositions for the treatment of angiotensin-related diseases
2017
drug development,
angiotensin,
therapeutic compounds,
disease treatment,
medical research
Evaluation of MMX1902 as an Oral Treatment for Duchenne Muscular Dystrophy
2016
drug efficacy,
duchenne muscular dystrophy,
clinical trial,
oral administration,
drug development
Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols
2015
chemical biology,
proteasome inhibitors,
polyphenols,
boron adducts,
molecular characterization
Abstract 1811: Evaluation of anti-CXCR2 small molecule inhibitors as novel chemotherapy targeting the Interleukin-8 pathway in colorectal cancer
2014
chemotherapy,
colorectal cancer,
small molecule inhibitors,
interleukin-8 pathway,
cxcr2 inhibitors
Collaborations
(11)
Bonnie LaFleur
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Andrew Rouse
Mutual work: 1 Proposal
Collaboration Details
Todd Vanderah
Mutual work: 1 Proposal
Collaboration Details
Elsa Reyes Reyes
Mutual work: 1 Grant
Collaboration Details
Theodore Trouard
Mutual work: 1 Grant﹒2 Proposals
Collaboration Details
Page 1 of 3
Previous page
Next page
News
(1)
Developing a Diverse Workforce To End the Alzheimer’s Epidemic
2019
Techs/Patents
(2)
Methods For Treating Or Limiting Development Of Cardiovascular Disease-Related Neurological Disorders
2023
·
Patent
Use of an Individual's Own Neural Network-Based Text To Speech Voice in Patients without Vocal Capacity Due to ALS and Other Conditions
2019
·
Technology
10+ Collaborators
$1.8M / $9.5M Funding
4+ Grants
10+ Publications
